Sickle cell disease: open trials in Germany

10 open trials have a site in Germany. Registry data; only the trial team decides who can take part.

NCT06975865
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Trial Treatment · Phase 3 · Sanofi
Berlin · Essen · Stuttgart
Registry updated 2026-10-15
NCT06699849
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
Trial Treatment · Phase 2 · CSL Behring
Medical Center- University of Freiburg, Freiburg im Breisgau
Registry updated 2026-10-08
NCT06609226
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Trial Treatment · Phase 3 · Novo Nordisk A/S
Charite Universitaetsmedizin Berlin KöR, Berlin · Medical Center- University of Freiburg, Freiburg im Breisgau
Registry updated 2026-09-18
NCT05431088
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
Trial Treatment · Phase 2/3 · Pfizer
Universitaetsklinikum Aachen AöR, Aachen · Marien Hospital Duesseldorf GmbH, Duesseldorf · Robert Bosch Krankenhaus GmbH, Stuttgart
Registry updated 2026-08-18
NCT04208529
A Long-term Follow-up Study in Participants Who Received CTX001
Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated
Universitaetsklinikum Duesseldorf AöR, Duesseldorf · Universitaetsklinikum Regensburg AöR, Regensburg · Universitaetsklinikum Tuebingen AöR, Tuebingen
Registry updated 2026-08-11
NCT04657822
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Universitaetsklinikum Heidelberg AöR, Heidelberg
Registry updated 2026-06-08
NCT05477563
Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
Trial Treatment · Phase 3 · Vertex Pharmaceuticals Incorporated
Universitaetsklinikum Duesseldorf AöR, Duesseldorf
Registry updated 2026-03-23
NCT06923111
PASS of Xromi Comparing Safety and Effectiveness in Children Under 2 Years With Sickle Cell Disease [PRECISE PASS]
Research · Nova Laboratories Limited
Universitätsklinikum Hamburg-Eppendorf, Hamburg · Universitätsklinikum Heidelberg, Heidelberg
Registry updated 2026-03-05
NCT03327428
Sickle-cell Disease Registry of the GPOH
Research · University Hospital Heidelberg
Center for Child and Adolescent Medicine, University Medical Center Heidelberg, Heidelberg
Registry updated 2025-01-24
NCT04201210
A Trial to Assess Haploidentical T-depleted Stem Cell Transplantation in Patients With SCD
Trial Treatment · Phase 2 · University of Regensburg
University Hospital Aachen, Children's Hospital, Aachen · Charité University medicine, Clinic for Hematology, Oncology, Berlin · University Hospital Duesseldorf, Clinic for Pediatric Oncology, - Hemtaology and Clinical Immunology, Düsseldorf · University Hospital of Frankfurt, Clinic for Paediatrics and Adolescent Medicine, Frankfurt · University Hospital Heidelberg, Department of Pediatric Hematology, Oncology and Immunology, Heidelberg · University Hospital Regensburg, Dept. of Ped. Hematology, Oncology and Stem Cell Transplantation, Regensburg · University Children's Hospital Tübingen, Tübingen · University Children's Hospital Würzburg, Würzburg
Registry updated 2024-05-13

All Sickle cell disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error